Office of the Director, National Institutes of Health; Notice of Meeting, 51868 [E9-23790]
Download as PDF
<![CDATA[
51868
Federal Register / Vol. 74, No. 194 / Thursday, October 8, 2009 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: November 2, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Courtyard Gaithersburg
Washingtonian Ctr., 204 Boardwalk Place,
Gaithersburg, MD 20878.
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Bethesda, MD 20892. 301–435–6902,
Peter.Zelazowski@Nih.Gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–24227 Filed 10–7–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Director’s Council of Public
Representatives.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Director’s Council of
Public Representatives.
Date: October 30, 2009.
Time: 9 a.m. to 5 p.m.
Agenda: Key topics for this meeting will
focus on emerging issues of public
importance in biomedical and behavioral
research. Further information will be
available on the COPR Web site.
Place: National Institutes of Health,
Building 31, Conference Room 6, 9000
Rockville Pike, Bethesda, MD 20852.
Contact Person: Kelli L. Carrington,
Executive Secretary/Public Liaison Officer,
VerDate Nov<24>2008
18:31 Oct 07, 2009
Jkt 220001
Office of Communications and Public
Liaison, Office of the Director, National
Institutes of Health, 9000 Rockville Pike,
Building 1, Room 344, Bethesda, MD 20892,
301–594–4575, carringk@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.copr.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 28, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–23790 Filed 10–7–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (NTP);
Report on Carcinogens (RoC);
Announcement of the Formaldehyde
Expert Panel Meeting: Amended Notice
AGENCY: National Institute of
Environmental Health Sciences
(NIEHS); National Institutes of Health
(NIH).
ACTION: Availability of web conferencing
and updated draft agenda.
SUMMARY: This notice announces the
availability of web conferencing and an
updated draft agenda for the RoC expert
panel meeting on formaldehyde. The
NTP has reserved web conferencing for
the first 50 registrants; individuals who
want to access the meeting remotely
must pre-register by October 21, 2009.
The web conferencing will be available
during the public sessions of the
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
meeting. The expert panel will meet on
November 2–4, 2009, starting at 8:30
AM Eastern Standard Time, at the
Hilton Raleigh-Durham Airport at
Research Triangle Park Hotel, 4810 Page
Creek Lane, Durham, NC 27703.
Information regarding the formaldehyde
expert panel meeting was announced in
the Federal Register (74 FR 44845)
published on August 31, 2009, and is
available on the RoC Web site (https://
ntp.niehs.nih.gov/go/29679). The
guidelines and deadlines published in
the August 31 Federal Register notice
for submitting written public comments
or making an oral presentation at the
meeting in North Carolina still apply.
DATES: The RoC expert panel will meet
on November 2–4, 2009, and convene
each day at 8:30 a.m. Eastern Standard
Time. October 21, 2009 is the deadline
for meeting registration and requests for
remote access. October 28, 2009 is the
deadline for submission of oral
statements and visual presentations.
ADDRESSES: The meeting will be held at
the Hilton Raleigh-Durham Airport at
Research Triangle Park Hotel, 4810 Page
Creek Lane, Durham, NC 27703. Access
to on-line registration to either attend
the meeting in person in North Carolina
or via Web conferencing is available on
the RoC Web site (https://
ntp.niehs.nih.gov/go/29679). Written
public comments should be sent to Dr.
Ruth M. Lunn, RoC Center, NIH/NIEHS,
P.O. Box 12233, MD K2–14, Research
Triangle Park, NC 27709, FAX: (919)
541–0144, or lunn@niehs.nih.gov.
Courier address: Report on Carcinogens
Center, 530 Davis Drive, Room 2006,
Morrisville, NC 27560. Persons needing
assistive technology in order to attend
the meeting via web conferencing
should contact Dr. Ruth Lunn (see FOR
FURTHER INFORMATION CONTACT below).
Requests should be made at least 7
business days in advance of the
meeting.
FOR FURTHER INFORMATION CONTACT: Dr.
Ruth M. Lunn, Director, RoC Center,
(919) 316–4637, lunn@niehs.nih.gov.
SUPPLEMENTARY INFORMATION:
Web Conferencing
In response to public interest in the
formaldehyde expert panel meeting, the
NTP will provide web conferencing to
facilitate remote access to the public
sessions of the meeting. Web
conferencing using Adobe ® Connect TM
will be available for the first 50
registrants. Individuals interested in
attending the meeting remotely must
register by October 21, 2009.
Registration can be completed online at
the RoC Web site (https://
ntp.niehs.nih.gov/go/29679) or by
E:\FR\FM\08OCN1.SGM
08OCN1
]]>Agencies
[Federal Register Volume 74, Number 194 (Thursday, October 8, 2009)]
[Notices]
[Page 51868]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-23790]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Director's Council of Public Representatives.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Director's Council of Public Representatives.
Date: October 30, 2009.
Time: 9 a.m. to 5 p.m.
Agenda: Key topics for this meeting will focus on emerging
issues of public importance in biomedical and behavioral research.
Further information will be available on the COPR Web site.
Place: National Institutes of Health, Building 31, Conference
Room 6, 9000 Rockville Pike, Bethesda, MD 20852.
Contact Person: Kelli L. Carrington, Executive Secretary/Public
Liaison Officer, Office of Communications and Public Liaison, Office
of the Director, National Institutes of Health, 9000 Rockville Pike,
Building 1, Room 344, Bethesda, MD 20892, 301-594-4575,
carringk@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.copr.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: September 28, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23790 Filed 10-7-09; 8:45 am]
BILLING CODE 4140-01-M
